Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 11;10(1):e0004335.
doi: 10.1371/journal.pntd.0004335. eCollection 2016 Jan.

Mycobacterium leprae-Infected Macrophages Preferentially Primed Regulatory T Cell Responses and Was Associated with Lepromatous Leprosy

Affiliations

Mycobacterium leprae-Infected Macrophages Preferentially Primed Regulatory T Cell Responses and Was Associated with Lepromatous Leprosy

Degang Yang et al. PLoS Negl Trop Dis. .

Abstract

Background: The persistence of Mycobacterium leprae (M. leprae) infection is largely dependent on the types of host immune responses being induced. Macrophage, a crucial modulator of innate and adaptive immune responses, could be directly infected by M. leprae. We therefore postulated that M. leprae-infected macrophages might have altered immune functions.

Methodology/principal findings: Here, we treated monocyte-derived macrophages with live or killed M. leprae, and examined their activation status and antigen presentation. We found that macrophages treated with live M. leprae showed committed M2-like function, with decreased interleukin 1 beta (IL-1beta), IL-6, tumor necrosis factor alpha (TNF-alpha) and MHC class II molecule expression and elevated IL-10 and CD163 expression. When incubating with naive T cells, macrophages treated with live M. leprae preferentially primed regulatory T (Treg) cell responses with elevated FoxP3 and IL-10 expression, while interferon gamma (IFN-gamma) expression and CD8+ T cell cytotoxicity were reduced. Chromium release assay also found that live M. leprae-treated macrophages were more resistant to CD8+ T cell-mediated cytotoxicity than sonicated M. leprae-treated monocytes. Ex vivo studies showed that the phenotype and function of monocytes and macrophages had clear differences between L-lep and T-lep patients, consistent with the in vitro findings.

Conclusions/significance: Together, our data demonstrate that M. leprae could utilize infected macrophages by two mechanisms: firstly, M. leprae-infected macrophages preferentially primed Treg but not Th1 or cytotoxic T cell responses; secondly, M. leprae-infected macrophages were more effective at evading CD8+ T cell-mediated cytotoxicity.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Viable M. leprae induced M2-type macrophage differentiation.
Peripheral blood monocytes were obtained from healthy volunteers and were differentiated into macrophages in vitro. Viable or heat-killed M. leprae were added to the macrophage culture for 6 days. (A) Cytokine expression by macrophages during coculture, as measured by Luminex assay. N = 6. (B) Mean fluorescence intensity (MFI) of MHC class II and CD163 expression on macrophages after 6-day incubation in all healthy volunteers. N = 6. *: p < 0.05. **: p < 0.01. ***: p < 0.001.
Fig 2
Fig 2. Macrophage treated with different M. leprae antigens showed committed functional differentiation.
Live M. leprae-infected macrophages or killed M. leprae-treated macrophages were either restimulated with killed M. leprae, or cultured in plain culture medium for 6 days. Cytokine expression during the restimulation period was measured by Luminex assay. **: p < 0.01. ***: p < 0.001.
Fig 3
Fig 3. Live M. leprae-infected macrophages preferentially primed Treg cell responses.
Autologous CD45RA+ naive T cells were incubated with live M. leprae-infected macrophages or killed M. leprae-treated macrophages for 6 days. The T cells were then negatively selected and incubated separately in anti-CD3/CD28-stimulated media for an additional 72 hours, after which the supernatant was collected for ELISA and cells for flow cytometry. (A) Summary of IFN-gamma and IL-10 concentration from all healthy volunteers in the supernatant. N = 6. (B) Ratio of IFN-gamma-to-IL-10 in each individual. (C) Mean fluorescence intensity (MFI) of FoxP3 expression in T cells from all treatment conditions. N = 6. *: p < 0.05. **: p < 0.01.
Fig 4
Fig 4. Macrophages incubated with viable M. leprae suppressed CD8+ T cell cytotoxicity.
Viable or killed M. leprae were incubated with T cells for 6 days, after which the CD8+ T cells were negatively purified from the coculture and were added to chromium-51-labeled target cells at the indicated effector-to-target ratio. (A) Percentage specific lysis using purified autologous monocyte loaded with sonicated M. leprae antigen as the target cells. (B) Percentage specific lysis using in vitro derived, M. leprae-infected macrophages as the target cells. The CD8+ T cell-induced cytotoxicity (isolated CD8+ T cell + target cell culture minus naive T cell + target cell culture) was shown in (C) and (D), at 27-to-1 effector-to-target ratio. The effectors are (C) CD8+ T cells incubated with killed M. leprae-stimulated macrophages and (D) CD8+ T cells incubated with live M. leprae-infected macrophages. N = 6, with two independent repetitions. *: p < 0.05. **: p < 0.01. ***: p < 0.001.
Fig 5
Fig 5. Peripheral blood monocytes and lesion site macrophages in L-lep patients exhibited high IL-10 and low TNF-alpha and MHC class II expressions.
(A) The cytokine expression profile by peripheral blood monocytes from L-lep (N = 13) and T-lep (N = 12) patients, as well as healthy volunteers (N = 6) following a 6-day incubation. (B) The MHC class II expression of peripheral blood monocytes from L-lep and T-lep patients and healthy volunteers. (C) The cytokine expression profile by lesion site macrophage from L-lep (N = 7) patients, following a 6-day incubation. (D) The MHC class II molecule expression of lesion site macrophages L-lep patients. *: p < 0.05.

Similar articles

Cited by

References

    1. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling P a., et al. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008;118: 2917–2928. 10.1172/JCI34189 - DOI - PMC - PubMed
    1. Walker SL, Lockwood DNJ. The clinical and immunological features of leprosy. Br Med Bull. 2006;77–78: 103–21. - PubMed
    1. Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ. 1974;51: 451–465. - PMC - PubMed
    1. Joosten SA, van Meijgaarden KE, Savage NDL, de Boer T, Triebel F, van der Wal A, et al. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A. 2007;104: 8029–34. - PMC - PubMed
    1. Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, van der Ploeg- van Schip JJ, et al. T-Cell Regulation in Lepromatous Leprosy. PLoS Negl Trop Dis. 2014;8. - PMC - PubMed

Publication types